The Panel of Experts Developing the Guidelines Also Looked at Two Other Drugs for Severe ... - Latest Tweet by World Health Organization

The panel of experts developing the guidelines also looked at two other drugs for severe & critical #COVID19: ruxolitinib and tofacitinib.
Given their uncertain effects, WHO made a conditional recommendation against their use https://t.co/UAc21Wgxbl https://t.co/Z39mSKrOv5— World Health Organization (WHO) (@WHO) January 14, 2022

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)